CD11c as a novel target to improve neutrophil effector functions and sepsis outcome
CD11c 作为改善中性粒细胞效应功能和脓毒症结局的新靶点
基本信息
- 批准号:10552923
- 负责人:
- 金额:$ 38.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdultAdvocateAgingAgonistBindingBiological AssayBiological MarkersBloodBone MarrowCD34 geneCRISPR/Cas technologyCell Adhesion MoleculesCell surfaceCellsChildCirculationClinical TrialsComplement ReceptorDataDendritic CellsDevelopmentEmergency SituationEscherichia coliFutureGenerationsGenesGenetic TranscriptionGoalsGranulocyte Colony-Stimulating FactorGranulopoiesisHL-60 CellsHematopoietic stem cellsHeterogeneityHospital MortalityHospitalizationHost DefenseHumanITGAX geneITGB2 geneImmuneIn VitroIncidenceInfectionIntegrin BindingIntegrinsInterventionKnock-in MouseKnockout MiceLeukocytesLigand BindingLigandsMicrobeModelingMorbidity - disease rateMusOntologyOperative Surgical ProceduresOutcomeOutputPatientsPhagocytesPlayPopulationProductionProliferatingReportingResearchRoleSamplingSepsisSignal PathwaySterilitySupportive careSystemic Inflammatory Response SyndromeTestingTherapeuticTherapeutic InterventionTimeTranslationsUnited StatesWild Type Mouseagedantagonistantimicrobialcandidate identificationcecal ligation puncturecostcytokineexperimental studyimprovedimproved outcomein vivomembermicrobialmortalitymouse modelneutrophilnovelnovel therapeuticsperipheral bloodpolymicrobial sepsisprecursor cellsepticseptic patientssingle-cell RNA sequencingsmall moleculetranscriptomic profiling
项目摘要
Project Summary/ Abstract
Sepsis remains to be associated with a high mortality of 20 to 30% with annual cost of $24 billion, accounting
for nearly one-fifth of the total aggregate costs in all the hospitalizations in the United States. Current sepsis
management is supportive. Therefore, identifying therapeutic approaches is an urgent task to improve the
outcome of sepsis. Neutrophils eradicate microbes as the first-line defense innate immune cells. In sepsis,
exaggerated de novo neutrophil production called emergency granulopoiesis occurs mainly via G-CSF
production. However, immature neutrophils are also released into a circulation to meet a high demand for
neutrophil number, but they have less antimicrobial defense functions, leading to worse host defense in septic
patients. G-CSF itself does not trigger full neutrophil maturation. Thus, an intervention to attain the
enhancement of neutrophil maturation is critical in sepsis for better host defense. Integrin CD11c was
considered a sensitive marker to differentiate sepsis from systemic inflammatory response syndrome. We
previously showed that CD11c KO mice had worse survival in the polymicrobial sepsis induced by cecal
ligation and puncture (CLP) surgery, indicating the critical role of CD11c in sepsis. There has been a paucity of
research about its functional role in vivo. We unexpectedly identified that CD11c was expressed in the bone
marrow (BM) neutrophils (largely intracellular) and its deficiency was associated with less BM neutrophil
maturation. In a mouse model to recapitulate emergency granulopoiesis, mature neutrophils were released in
significantly less quantity in CD11c KO mice compared to wild type (WT) mice, further suggesting its
importance in neutrophil maturation. We created CD11c constitutively active knock-in (KI) mice, which
demonstrated to have more mature neutrophils in the BM in a steady-state condition and during infection with
better bacterial eradication and outcomes. In addition, our in vitro neutrophil maturation experiments using
primary murine CD11c KO neutrophils or HL-60 cells devoid of CD11c by CRISPR/Cas9 technology showed
less neutrophil maturation. Based on these results, we hypothesized that CD11c activity would significantly
regulate the degree of neutrophil maturation in a steady state and emergency granulopoiesis in a cell-intrinsic
manner. Our preliminary data suggested that CD11c would also regulate a subset of neutrophil effector
functions irrelevant of maturation. Thus, we will determine the role of CD11c in neutrophil maturation and
effector functions in a steady state and sepsis in Aim 1 and Aim 2. Because IQGAP1 was suggested to be a
binding partner for CD11c, its role will also be studied to delineate the mechanism of how CD11c regulates
neutrophil maturation and effector functions. Studies will be done by using human sepsis subjects and murine
models. Because there are no CD11c small molecule agonists and antagonists available, we will screen them
in Aim 3. Upon the completion of the proposal, we expect that we would solidify that CD11c would be a critical
regulator of neutrophil maturation and effector functions for a therapeutic intervention in sepsis.
项目总结/摘要
脓毒症仍然与20%至30%的高死亡率相关,每年花费240亿美元,
占美国所有住院总费用的近五分之一。当前脓毒症
管理层是支持的。因此,确定治疗方法是改善
脓毒症的结果。中性粒细胞作为第一道防线消灭微生物的先天免疫细胞。在败血症中,
称为紧急粒细胞生成的中性粒细胞从头产生过多主要通过G-CSF发生
生产然而,未成熟的中性粒细胞也被释放到循环中以满足对中性粒细胞的高需求。
中性粒细胞的数量,但他们有较少的抗菌防御功能,导致更差的主机防御脓毒症
患者G-CSF本身并不触发中性粒细胞的完全成熟。因此,一项旨在实现
增强中性粒细胞成熟对于更好的宿主防御在脓毒症中是关键的。整合素CD 11 c为
被认为是区分脓毒症和全身炎症反应综合征的敏感标志物。我们
先前的研究表明,CD 11 c KO小鼠在盲肠炎诱导的多微生物脓毒症中的存活率较差,
结扎和穿刺(CLP)手术,表明CD 11 c在脓毒症中的关键作用。一直以来,
研究其在体内的功能作用。我们出乎意料地发现,CD 11 c在骨中表达,
骨髓(BM)中性粒细胞(主要是细胞内),其缺乏与BM中性粒细胞减少有关
成熟在一个小鼠模型中重现了紧急粒细胞生成,成熟的中性粒细胞被释放,
与野生型(WT)小鼠相比,CD 11 c KO小鼠中的量显著更少,进一步表明其
中性粒细胞成熟的重要性。我们建立了CD 11 c组成型活性敲入(KI)小鼠,
在稳态条件下和感染期间,
更好的细菌根除和结果。此外,我们的体外中性粒细胞成熟实验,
通过CRISPR/Cas9技术检测的原代鼠CD 11 c KO中性粒细胞或缺乏CD 11 c的HL-60细胞显示,
中性粒细胞成熟较少。基于这些结果,我们假设CD 11 c活性将显著影响
调节稳定状态下中性粒细胞成熟的程度和细胞内在的紧急粒细胞生成
方式我们的初步数据表明,CD 11 c也可以调节中性粒细胞效应子的一个亚群,
与成熟无关的功能。因此,我们将确定CD 11 c在中性粒细胞成熟中的作用,
稳态下的效应子功能和目标1和目标2中的脓毒症。因为IQGAP 1被认为是一个
结合配偶体的CD 11 c,其作用也将进行研究,以阐明如何CD 11 c调节的机制,
中性粒细胞成熟和效应子功能。研究将通过使用人脓毒症受试者和小鼠进行。
模型因为没有CD 11 c小分子激动剂和拮抗剂,我们将筛选它们
目标3。在提案完成后,我们预计我们将巩固CD 11 c将是一个关键的
中性粒细胞成熟和效应子功能的调节剂,用于脓毒症的治疗干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Koichi Yuki其他文献
Koichi Yuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Koichi Yuki', 18)}}的其他基金
The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
损伤相关分子模式在小儿先天性心脏病围手术期发病率和死亡率中的作用
- 批准号:
10669290 - 财政年份:2022
- 资助金额:
$ 38.94万 - 项目类别:
The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
损伤相关分子模式在小儿先天性心脏病围手术期发病率和死亡率中的作用
- 批准号:
10492851 - 财政年份:2022
- 资助金额:
$ 38.94万 - 项目类别:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
囊性纤维化患者肺部病理生理学麻醉/镇静方案的优化
- 批准号:
10181647 - 财政年份:2021
- 资助金额:
$ 38.94万 - 项目类别:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
囊性纤维化患者肺部病理生理学麻醉/镇静方案的优化
- 批准号:
10341229 - 财政年份:2021
- 资助金额:
$ 38.94万 - 项目类别:
Surgical site infections and the role of anesthesia and bacterial ion transporters
手术部位感染以及麻醉和细菌离子转运蛋白的作用
- 批准号:
10402288 - 财政年份:2020
- 资助金额:
$ 38.94万 - 项目类别:
Surgical site infections and the role of anesthesia and bacterial ion transporters
手术部位感染以及麻醉和细菌离子转运蛋白的作用
- 批准号:
9883315 - 财政年份:2020
- 资助金额:
$ 38.94万 - 项目类别:
The impact of anesthetic selection on sepsis outcome and its mechanism
麻醉选择对脓毒症结局的影响及其机制
- 批准号:
9250801 - 财政年份:2016
- 资助金额:
$ 38.94万 - 项目类别:
The impact of anesthetic selection on sepsis outcome and its mechanism
麻醉选择对脓毒症结局的影响及其机制
- 批准号:
9452998 - 财政年份:2016
- 资助金额:
$ 38.94万 - 项目类别:
The impact of anesthetic selection on sepsis outcome and its mechanism
麻醉选择对脓毒症结局的影响及其机制
- 批准号:
9072087 - 财政年份:2016
- 资助金额:
$ 38.94万 - 项目类别:
Immunomodulatory mechanism of volatile anesthetics
挥发性麻醉药的免疫调节机制
- 批准号:
8449579 - 财政年份:2012
- 资助金额:
$ 38.94万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 38.94万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 38.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




